Pharmerging Market - Generic Drug Production and Cost-Effective Treatment
Market Overview The pharmerging market is experiencing generic medicine emphasis where generic drug manufacturing, affordability focus, and cost-effective treatments meet healthcare access needs in emerging economies. The pharmerging market is projected to exceed USD 684.2 billion through 2030, with generic emphasis driven by affordability necessity, disease burden, and cost constraints....
0 Kommentare 0 Geteilt 3 Ansichten 0 Bewertungen